全文获取类型
收费全文 | 3124篇 |
免费 | 285篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 99篇 |
妇产科学 | 80篇 |
基础医学 | 376篇 |
口腔科学 | 198篇 |
临床医学 | 301篇 |
内科学 | 546篇 |
皮肤病学 | 58篇 |
神经病学 | 344篇 |
特种医学 | 137篇 |
外科学 | 387篇 |
综合类 | 76篇 |
预防医学 | 354篇 |
眼科学 | 99篇 |
药学 | 237篇 |
中国医学 | 1篇 |
肿瘤学 | 123篇 |
出版年
2021年 | 47篇 |
2020年 | 27篇 |
2019年 | 43篇 |
2018年 | 55篇 |
2017年 | 44篇 |
2016年 | 30篇 |
2015年 | 45篇 |
2014年 | 58篇 |
2013年 | 82篇 |
2012年 | 111篇 |
2011年 | 156篇 |
2010年 | 76篇 |
2009年 | 73篇 |
2008年 | 95篇 |
2007年 | 137篇 |
2006年 | 120篇 |
2005年 | 124篇 |
2004年 | 111篇 |
2003年 | 99篇 |
2002年 | 105篇 |
2001年 | 72篇 |
2000年 | 84篇 |
1999年 | 88篇 |
1998年 | 50篇 |
1997年 | 45篇 |
1996年 | 37篇 |
1995年 | 45篇 |
1994年 | 34篇 |
1993年 | 30篇 |
1992年 | 73篇 |
1991年 | 49篇 |
1990年 | 61篇 |
1989年 | 76篇 |
1988年 | 63篇 |
1987年 | 69篇 |
1986年 | 83篇 |
1985年 | 69篇 |
1984年 | 54篇 |
1983年 | 56篇 |
1982年 | 34篇 |
1981年 | 31篇 |
1979年 | 53篇 |
1978年 | 45篇 |
1977年 | 43篇 |
1976年 | 42篇 |
1974年 | 35篇 |
1973年 | 38篇 |
1971年 | 28篇 |
1970年 | 31篇 |
1969年 | 39篇 |
排序方式: 共有3436条查询结果,搜索用时 0 毫秒
71.
72.
J.M. Batchelor A. Chapman F.E. Craig K.E. Harman G. Kirtschig A. Martin‐Clavijo A.D. Ormerod S. Walton H.C. Williams 《The British journal of dermatology》2017,177(5):e228-e234
Clinical trials may benefit clinical practice in three ways: firstly, clinicians may change their practice according to the new trial evidence; secondly, clinical processes can improve when working on a trial; and thirdly, research capacity is increased. We held a meeting to present and discuss the results of two large multicentre randomized controlled trials delivered through the U.K. Dermatology Clinical Trials Network. Investigators gave reflections on how the trials had changed their clinical practice. The STOP GAP trial showed that prednisolone and ciclosporin are equally effective as first‐line systemic treatment for pyoderma gangrenosum. The final decision of which treatment to use should be based on the different adverse event profiles of the two drugs in relation to comorbidities, along with age, disease severity and patient preference. The BLISTER trial showed that starting people with pemphigoid on doxycycline produces acceptable short‐term effectiveness and a superior safety profile to oral corticosteroids. Recruiting to these trials has led to the development of new specialist clinics with improved documentation. It has increased the profile of participating departments and embedded research in the department's activities. Helping to design and run these trials has also allowed trial staff to develop new skills in research design, which has been beneficial for career development. These and other benefits of recruiting to the trials are summarized here. We hope that these reflections will inspire wider involvement in clinical research. 相似文献
73.
74.
75.
76.
77.
Karen Walton 《Nutrition & Dietetics》2011,68(3):239-240
78.
Does the presence of hibernating myocardium in patients with impaired left ventricular contraction affect QT dispersion? 总被引:4,自引:0,他引:4
Al Mohammad A Mahy IR Buckley A Cargill RI Norton MY Welch AE Walton S 《American heart journal》2001,141(6):944-948
BACKGROUND: Hibernating myocardium is associated with increased cardiovascular events. Increased QT dispersion on the surface electrocardiogram is a marker for serious ventricular arrhythmias. In this study, we determine whether hibernating myocardium is associated with increased QT dispersion in patients with coronary artery disease and impaired left ventricular contraction. METHODS: Positron emission tomography with (13)N-ammonia and (18)F-fluorodeoxyglucose determined the presence of metabolic-perfusion mismatch defect. QT dispersion was measured by means of a digitizing tablet with validated software. QT intervals were measured on two separate occasions by two investigators blinded to the result of the positron emission tomography scans. RESULTS: Forty-two patients with impaired left ventricular contraction were studied. They were divided into two groups: group A was made up of patients with mismatch defects (n = 26) and group B was made up of patients with no mismatch defects (n = 16). The mean (SD) QT dispersion measurements were 61.7 +/- 29.8 ms and 70 +/- 24.6 ms for groups A and B, respectively (not significant). When the patients were divided according to the dominant viability status of the impaired myocardial segment, a similar result was found. The patients whose impaired myocardium was dominantly hibernating (n = 19) had a mean QT dispersion of 66.4 +/- 31.9 ms compared with 63.6 +/- 24.8 ms in the patients whose impaired myocardium was mainly scarred (not significant). CONCLUSIONS: QT dispersion is not affected by the presence of hibernating myocardium and is therefore not clinically useful in identifying patients with this phenomenon. This is in contrast with recent reports by other groups and calls for further investigation of this dichotomy. 相似文献
79.
Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4 总被引:4,自引:0,他引:4
Leukotriene B4 (LTB4) is a potent primary stimulator of neutrophil chemotaxis, aggregation, and degranulation and induces superoxide production at higher concentrations. In order to determine whether LTB4 modulates neutrophil responses to oxidative stimuli, human neutrophils (PMNs) were incubated with LTB4 prior to stimulation with f-Met-Leu-Phe (fMLP, 10(-7) mol/L), opsonized zymosan (OZ, 250 micrograms/mL), or phorbol myristate acetate (PMA, 32 nmol/L). Superoxide (O2-) production by stimulated PMNs was assessed by the superoxide dismutase-inhibitable reduction of cytochrome c. LTB4 alone did not stimulate O2- production in concentrations below 10(-7) mol/L and had no effect on the O2- assay. In the concentration range of 10(-12) to 10(-8) mol/L, LTB4 did not alter O2- release induced by OZ or PMA. In contrast, LTB4-treated cells demonstrated enhanced O2- production following exposure to fMLP, and in the presence of 10 nmol/LLTB4, generated 180% +/- 41% of O-2 quantities produced by control cells (n = 23). Enhancement was LTB4 dose-dependent, was maximal in the range of 1 to 10 nmol/L LTB4, was not reversed by removal of the lipid from the medium prior to fMLP stimulation, and was not dependent on the presence of Ca++ or Mg++ in the suspending medium. Chemiluminescence of fMLP-stimulated neutrophils was increased to 323% of controls in neutrophils preincubated with 10 nmol/L LTB4. Unlike augmentation of oxidative responses to fMLP seen with other degranulating stimuli, enhancement by LTB4 was not correlated with an increase in 3H-fMLP receptor binding. These results indicate that, in addition to its primary effects on neutrophil function, LTB4 modulates PMN oxidative responses to the chemotactic peptide and, thus, may amplify the release of oxygen metabolites at inflammatory foci. 相似文献
80.
Physical and functional interactions between Stat5 and the tyrosine- phosphorylated receptors for erythropoietin and interleukin-3 总被引:3,自引:1,他引:3
Erythropoietin (Epo) and interleukin-3 (IL-3) stimulate activation of the Jak2 tyrosine kinase and induce tyrosine phosphorylation and activation of Stat5. In the present study, we have shown that Epo or IL- 3 stimulation induces binding of Stat5 to the tyrosine-phosphorylated Epo receptor (EpoR) or IL-3 receptor beta subunit (betaIL3), respectively, in IL-3-dependent 32D cells expressing the EpoR. The binding of Stat5 to these cytokine receptors was shown to be rapid and transient, occurring within 1 minute of stimulation of cells and significantly decreasing after 5 minutes of cell treatment. In vivo binding experiments in COS cells showed that binding of Stat5 to the EpoR was mediated through the Stat5 Src homology 2 (SH2) domain. In vitro binding studies further showed that Stat5, but not other Stats examined, bound specifically to tyrosine-phosphorylated recombinant EpoR fusion proteins. In these in vivo and in vitro binding studies, Stat5 bound, albeit to a lesser degree, to truncated EpoR mutants in which all the intracellular tyrosines except Y-343 were removed. Furthermore, EpoR-derived synthetic phosphotyrosine peptides corresponding to Y-343, Y-401, Y-431, and Y-479 inhibited the in vitro binding of Stat5. When expressed in 32D cells, a mutant EpoR in which all the intracellular tyrosines were removed by carboxy-terminal truncation showed a significantly impaired ability to induce tyrosine phosphorylation of Stat5, particularly at low concentrations of Epo, but exhibited an increased sensitivity to Epo for growth signaling as compared with the wild-type EpoR. These results indicate that Stat5 specifically and transiently binds to the EpoR through the interaction between the Stat5 SH2 domain and specific phosphorylated tyrosines, including Y-343, in the EpoR cytoplasmic domain. It was implied that betaIL3 may also have similar Stat5 docking sites. The Stat5 docking sites in the EpoR were shown to facilitate specific activation of Stat5, which, however, may not be required for the EpoR-mediated growth signaling. 相似文献